Zihang Xu

Zihang Xu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
HLHeming Li
Heming Li
YZYang-Zhuangzhuang Zhu
Yang-Zhuangzhuang Zhu
LXLu Xu
Lu Xu
THTao Han
Tao Han
JLJiasi Luan
Jiasi Luan
MZMingfang Zhao
Mingfang Zhao
Background: Circulating tumor cells (CTCs) hold immense promise in guiding treatment strategies for advanced gastric cancer (GC). However, their clinical impact has been limited due to challenges in identifying epithelial-mesenchymal transition (EMT)-CTCs using conventional methods. Methods: To bridge this knowledge gap, we established a detection platform for CTCs based on the distinctive biomarker cell surface vimentin (CSV). A prospective study involving 127 GC patients was conducted, comparing CTCs enumeration using both EpCAM and CSV. This approach enabled the detection of both regular and EMT-CTCs, providing a comprehensive analysis. Spiking assays and WES were employed to verify the reliability of this marker and technique. To explore the potential inducer of CSV+CTCs formation, a combination of Tandem Mass Tag (TMT) quantitative proteomics, m6A RNA immunoprecipitation–qPCR (MeRIP–qPCR), single-base elongation- and ligation-based qPCR amplification method (SELECT) and RNA sequencing (RNA-seq) were utilized to screen and confirm the potential target gene. Both in vitro and in vivo experiments were performed to explore the molecular mechanism of CSV expression regulation and its role in GC metastasis. Results: Our findings revealed the potential of CSV in predicting therapeutic responses and long-term prognosis for advanced GC patients. Additionally, compared to the conventional EpCAM-based CTCs detection method, the CSV-specific positive selection CTCs assay was significantly better for evaluating the therapeutic response and prognosis in advanced GC patients and successfully predicted disease progression 14.25 months earlier than radiology evaluation. Apart from its excellent role as a detection marker, CSV emerges as a promising therapeutic target for attenuating GC metastasis. It was found that fat mass and obesity associated protein (FTO) could act as a potential catalyst for CSV+CTCs formation, and its impact on the insulin-like growth factor-I receptor (IGF-IR) mRNA decay through m6A modification. The activation of IGF-I/IGF-IR signaling enhanced the translocation of vimentin from the cytoplasm to the cell surface through phosphorylation of vimentin at serine 39 (S39). In a GC mouse model, the simultaneous inhibition of CSV and blockade of the IGF-IR pathway yielded promising outcomes. Conclusion: In summary, leveraging CSV as a universal CTCs marker represents a significant breakthrough in advancing personalized medicine for patients with advanced GC. This research not only paves the way for tailored therapeutic strategies but also underscores the pivotal role of CSV in enhancing GC management, opening new frontiers for precision medicine.

1 November 2020 in Cancer Letters
Verified
Journal Article
Closed access
CYChao Yao
Chao Yao
LSLin Su
Lin Su
FZFei Zhang
Fei Zhang
XZXiaowen Zhu
Xiaowen Zhu
YZYangzhuangzhuang Zhu
Yangzhuangzhuang Zhu
ZXZihang Xu
Zihang Xu

31 July 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
YHYifei Hou
Yifei Hou
HZHuimin Zhang
Huimin Zhang
YZYangzhuangzhuang Zhu
Yangzhuangzhuang Zhu
XHXufeng He
Xufeng He
WLWen Li
Wen Li
ZXZihang Xu
Zihang Xu

16 April 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LSLin Su
Lin Su
FZFei Zhang
Fei Zhang
MLMing-Xi Liu
Ming-Xi Liu
HLHong Li
Hong Li
QLQiang Li
Qiang Li
CZChunpu Zou
Chunpu Zou

8 October 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MLMing-Xi Liu
Ming-Xi Liu
LSLin Su
Lin Su
XZXiao-Wen Zhu
Xiao-Wen Zhu
YZYang-Zhuangzhuang Zhu
Yang-Zhuangzhuang Zhu
XCXiao Chen
Xiao Chen
ZXZihang Xu
Zihang Xu

26 March 2024 in Phytomedicine
Verified
Journal Article
Closed access
YZYangzhuangzhuang Zhu
Yangzhuangzhuang Zhu
XCXi Chen
Xi Chen
YZYimeng Zou
Yimeng Zou
LSLin Su
Lin Su
XYXuewei Yan
Xuewei Yan
ZXZihang Xu
Zihang Xu